A letter from FDA indicated a delay on future Deeming Regulation compliance deadlines by 3 months, the reason for the extension stated in the letter is that; ” This extension will allow new leadership at the FDA and the Department of Health and Human Services additional time to more fully consider issues raised by the
First, Aspire, being the premiere vaporizer company recognizes the need to regulate the current vaporizer market. Regulation will mean that vaping consumers are properly protected when using vaping hardware and e-liquid juices. Second, Aspire is here to stay. We are ready to fully comply and Aspire will continue to be an industry leader and innovator.